• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News

News · February 9, 2011

Evotec – Expanding its drug discovery platform with cutting-edge technologies

· Adds propriEtary Technologies for response prediction and Drug efficacy and safety assessment; especially in Key indication area oncology · Adds fast growing business with an expected revenue of € …

News · February 8, 2011

Rapid Micro Biosystems Partners with Life Technologies Corporation on Automated Microbial Detection– Growth Direct™ System

Businesses team to accelerate microbial detection and identification. Bedford, MA - (February 8, 2011)– Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial …

News · February 2, 2011

Concert Pharmaceuticals Enters Into a Cooperative Research and Development Agreement with Walter Reed Army Institute of Research to Evaluate Neuroprotective Drug Compound

Advances Concert’s R&D for Novel Drugs to Treat Seizure-Generating Diseases and Injuries February 2, 2011 Lexington, MA -- Concert Pharmaceuticals, Inc. today announced that it has entered into a …

News · January 31, 2011

Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics´ Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial

—In Vitro Results Published in Journal of Immunotherapy Demonstrate That Potency of Mature CD40L RNA Electroporated DCs Correlates with IL-12 Secretion by Tracking Multifunctional CD8(+)/CD28(+) …

News · January 26, 2011

CyDex Pharmaceuticals Approves Merger with Ligand Pharmaceuticals

Transaction Closed Today Expected to Accelerate Development of CyDex’s Captisol® Franchise LENEXA, Kansas – January 26, 2011 – CyDex Pharmaceuticals, Inc. today announced that its stockholders have …

News · January 25, 2011

MediGene Adds Romania and Bulgaria to Existing Partnership Agreement with Meditrina for the Commercialization of Veregen®

Martinsried/Munich, January 25, 2011. The biotech company MediGene AG (Frankfurt, Prime Standard) announced today that its existing partnership with Meditrina Pharmaceuticals Ltd., Greece, for the …

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 47
  • Go to page 48
  • Go to page 49
  • Go to page 50
  • Go to page 51
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement

August 1, 2022

Kent Imaging Recognized as Most Innovative Medical Imaging Technology Developer in Canada

June 23, 2022

Egg Medical hatches technology to shield health care workers from radiation

March 29, 2022

Egg Medical hatches $13M VC funding

March 15, 2022

Egg Medical, Inc., Closes on $13 million Financing

March 3, 2022

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact